Beranda › Leukemia › California › Los Angeles
Uji klinis Leukemia di Los Angeles, CA
16 studi untuk Leukemia mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 7, Los Angeles
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Menerima pesertaFase 2
- USC Norris Comprehensive Cancer Center, Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- UCLA Medical Center, Los Angeles
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Children s Hospital of Los Angeles, Los Angeles
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Menerima pesertaFase 1/2
- Research Site, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Menerima pesertaFase 2
- Children's Hospital Los Angeles, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- Valkyrie Clinical Trials, Los Angeles
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Menerima pesertaFase 1/2
- David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 2
- UCLA Department of Medicine, Los Angeles
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Menerima pesertaFase 2/3
- Keck School of Medicine of USC, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Menerima pesertaFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Menerima pesertaFase 1
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Menerima pesertaSukarelawan sehat diterima
- Children's Hospital Los Angeles, Los Angeles
Uji klinis Leukemia di kota lain
- Houston, TX28 studi
- Boston, MA25 studi
- New York City, NY19 studi
- Chicago, IL16 studi
- Durham, NC13 studi
- Philadelphia, PA12 studi
- Columbus, OH12 studi
- Nashville, TN12 studi
- Baldwin Park, CA12 studi
- Milwaukee, WI11 studi
- Seattle, WA11 studi
- Atlanta, GA11 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker (semua jenis)74 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.